As a consequence, diabetes-induced hyperglycemia or SGLT2 inhibition would increase induced glucose transport facilitated by the SGLT1 transporter, which is the rational basis for dual inhibition of SGLT1/2 (see below) [19]. Here, SLC5A2 is linked to diabetes mellitus.